0000914190-13-000565.txt : 20130827 0000914190-13-000565.hdr.sgml : 20130827 20130827175926 ACCESSION NUMBER: 0000914190-13-000565 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130823 FILED AS OF DATE: 20130827 DATE AS OF CHANGE: 20130827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 651 CAMPUS DRIVE CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kenny Kevin J CENTRAL INDEX KEY: 0001520400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 131063789 MAIL ADDRESS: STREET 1: 4234 GREENVIEW DRIVE CITY: EL DORADO HILLS STATE: CA ZIP: 95762 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-08-23 0001180145 Cardiovascular Systems Inc CSII 0001520400 Kenny Kevin J 651 CAMPUS DRIVE ST. PAUL MN 55112 0 1 0 0 Exec. VP, Sales & Mtkg Common Stock 2013-08-23 4 S 0 505 20.88 D 91570 D Common Stock 2013-08-26 4 S 0 1115 21.29 D 90455 D Common Stock 2013-08-27 4 S 0 776 20.88 D 89679 D In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.59 to $21.06 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.48 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80 to $21.03 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Scott J. Dorfman as Attorney-in-Fact for Kevin J. Kenny pursuant to Power of Attorney previously filed. 2013-08-27